Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 410-690-9 | CAS number: 103055-07-8 CGA 184699
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: inhalation
Administrative data
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 22 Mar 1988 to 12 Apr 1988
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 988
- Report date:
- 1988
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Version / remarks:
- May 1981
- GLP compliance:
- yes
- Test type:
- traditional method
- Limit test:
- yes
Test material
- Reference substance name:
- N-[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)-phenyl-aminocarbonyl]-2,6-difluorobenzamide
- EC Number:
- 410-690-9
- EC Name:
- N-[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)-phenyl-aminocarbonyl]-2,6-difluorobenzamide
- Cas Number:
- 103055-07-8
- Molecular formula:
- C17 H8 Cl2 F8 N2 O3
- IUPAC Name:
- 1-[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl]-3-(2,6-difluorobenzoyl)urea
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Tif: RAI f (SPF) hybrids of RII/1 x RII/2
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Age at study initiation: age 7 - 8 weeks
- Weight at study initiation: 178 to 331 g
- Housing: Group of 5 (by sex); Macrolon cages, Type 4 with standardised soft wood bedding
- Diet: Rat diet, ad libitum.
- Water: ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 2
- Humidity (%): 55 ± 10
- Air changes (per hr): approximately 15
- Photoperiod (hrs dark / hrs light): 12 / 12
IN-LIFE DATES: From: 22 Mar 1988 To: 12 Apr 1988
Administration / exposure
- Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- nose only
- Vehicle:
- air
- Mass median aerodynamic diameter (MMAD):
- >= 1.9 - <= 2.8 µm
- Geometric standard deviation (GSD):
- >= 2.2 - <= 2.5
- Remark on MMAD/GSD:
- In of the vicinity of the animals, 84 to 95 % (weight) of the airborne particles had a diameter smaller than 7 μm during the exposure.
- Details on inhalation exposure:
- INHALATION EXPOSURE CHAMBER
All exposures were conducted in a nose-only exposure. The chamber was designed to ensure a rapid equilibration (internal active volume less than one litre) and a uniform exposure of all animals in the system. In order to avoid rebreathing of the exhaled air, "fresh" test substance (in first—pass chamber air) was supplied to each animal via individual delivery and exhaust tubes. In addition to the necessary animal and sampling ports, identical "void" outlets were opened in proportion to the total air flow through the chamber. Thus the flow in any individual aerosol delivery tube was standardized to 2 L/min (velocity 1.25 m/s).
For the inhalation period, the rats were placed in Macrolon animal holders positioned radially around the exposure chamber, so that only the snouts and nostrils of the animals were exposed to the aerosol. The chamber was maintained at an exactly balanced pressure to prevent leakage of the test atmosphere from the system, as well as dilution with outside air. The exhaust air was decontaminated by subsequent passage through an absolute filter. The aerosol concentration in the chamber was determined gravimetrically 5 times during the exposure period. Samples of the test atmosphere (1 L) were passed through a GP 92 filter. The air flow rate for the sample collection was kept constant (2 L/min) by means of a Sierra Series 110 constant flow air sampler, regardless of filter loading. The mean and standard deviation of the aerosol concentrations for the exposure was calculated. Particle size analysis was conducted with an APS-33 Aerodynamic Particle Sizer, equipped with appropriate dilution systems to avoid coincidence counts. The number distribution in the 48 size classes was converted to a mass distribution, based on the bulk density of the test substance, which was determined separately. The following environmental parameters inside the inhalation chamber were monitored at approximately the same intervals as the concentration determinations:
- Temperature
- Relative humidity
- Oxygen content
AEROSOL
The aerosol was generated from the solid test material by means of a brush-feed micronizing jet mill. The aerosol generation system consists of a dual flexible brush dust-feed mechanism, modified from a design by Milliman, and a jet mill, to be aerodynamically compatible with the brush feed and the exposure system. In this instrument, powders are transferred from a hopper brush through a slit interface to the aspiration tube of the jet mill by means of a spiral feed brush driven by a stepping motor. In the mill, the material is micronized by impaction of particle against particle in two opposing air streams. A cyclone type classifier ensures that only particles of the desired diameter leave the jet mill, while the larger ones are re-entrained into the air stream for further milling. In a preliminary experiment, the appropriate interface slit size, brush speeds, and air pressures and flows were determined for the desired concentration. The dust generator was operated at a total airflow (through the aspiration tube and the two milling jets) of 37 L/min (input pressure 210/210 kPa), and the aerosol was diluted with filtered humidified air to yield a total flow of 48 L/min. Secondary agglomerates were removed from the aerosol by means of a glass cyclone. The throughput of the solid test material was determined by weighing the dust genera tor and the cyclone before and after aerosol generation. The control animals were exposed to filtered humidified air (32 L/min) under the same conditions as described above.
ANALYSIS OF INHALATION ATMOSPHERES
The air flow through the chamber was measured with flow meters. Adjustments to maintain a total flow of 48 L/min could be made with needle valves. However, no deviations were observed in any of the exposures, once the equilibrium was reached (within the first 10 minutes after beginning of exposure). - Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 4 h
- Concentrations:
- 2350 ± 100 mg/m³
- No. of animals per sex per dose:
- 5
- Control animals:
- yes
- Details on study design:
- OBSERVATIONS
MORBIDITY/MORTALITY
The animals were examined for clinical symptoms and mortalities during the exposure at 1, 2, and 4 hours, as well as 2 hours after the exposure and daily thereafter for 14 days.
BODY WEIGHTS
Body weights were recorded immediately prior to exposure and on days 7 and 14 of the observation period.
GROSS PATHOLOGY
Examinations were performed on all animals, which were killed after 14 days by ether anaesthesia. Particular attention was given to the respiratory tract - Statistics:
- Inhalation LC50 values (including their 95 % confidence limits) for a 4 hour treatment and a subsequent 14 day observation period could not be calculated, because no mortalities were elicited by the test substance at a concentration of 2350 ± 100 mg/m3 (limit test). The body weights of the treated animals and the controls were compared by analysis of variance.
Results and discussion
Effect levels
- Key result
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 2 350 mg/m³ air (analytical)
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Mortality:
- No mortality occurred.
- Clinical signs:
- other: The symptoms, piloerection, hunched posture, dyspnea, were seen and in similar extent in both sexes. These findings disappeared within 2 days.
- Body weight:
- The males exposed to the test article exhibited a significantly higher body weight increase during the second week after exposure
- Gross pathology:
- No treatment-related deviations from normal morphology were detected at necropsy.
Any other information on results incl. tables
Table 1 Exposure atmospheres
Parameter |
1 - Control Group (air) |
2 – Exposure Group (test substance) |
Exposure day |
22 Mar 1988 |
12 April 1988 |
Nominal concentration (mg/m3) |
Control * |
3003 |
Mean exposure concentration ** (mg/m3) ± SD |
2350 ± 100 |
|
Mass median aerodynamic diameter (MMAD) (mm) |
1.9 – 2.8 |
|
Geometric standard deviation (GSD) |
2.2 – 2.5 |
|
Particles < 7 mm (% w/w) |
84 – 95 |
|
Particles < 3 mm (% w/w) |
52 – 73 |
|
Air flow (L/min) through generator |
32 |
37 |
Mean chamber temperature (ºC) *** ± SD |
22.3 ± 0.1 |
23.0 ± 0.1 |
Mean relative humidity (%) *** ± SD |
47 ± 1 |
38 ± 1 |
Mean oxygen content (%) *** ± SD |
21.0 ± 0 |
21.0 ± 0 |
* exposed to filtered humidified air
** determined gravimetrically 5 times during exposure period
*** determined 5 times during the exposure period
Table 2 Observation of symptoms
Observations |
Exp. day |
Day of post exposure period |
||||||||||
de |
ae |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
>9 |
|
Control males |
|
|
no effect observed in all animals |
|||||||||
Test article exposed males |
|
|
|
|
|
|
|
|
|
|
|
|
piloerection |
|
++ |
+ |
|
|
|
|
|
|
|
|
|
hunched post. |
|
+ |
|
|
|
|
|
|
|
|
|
|
dyspnoea |
|
++ |
+ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Control females |
|
|
no effect observed in all animals |
|||||||||
Test article exposed females |
|
|
|
|
|
|
|
|
|
|
|
|
piloerection |
|
++ |
+ |
|
|
|
|
|
|
|
|
|
hunched post. |
|
+ |
|
|
|
|
|
|
|
|
|
|
dyspnoea |
|
++ |
+ |
|
|
|
|
|
|
|
|
|
Exp.day = exposure day (de = during, ae = after exposure)
+ = slight ++ moderate = +++ = severe
hunched post. = hunched posture
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The acute inhalation LC50 of the test substance in rats was found to be greater than 2350 mg/m3 for both males and females.
- Executive summary:
The acute inhalation toxicity of the test substance was evaluated in groups of 5 male and 5 female young adult albino rats (Tif: RAI f (SPF)), rats in accordance with OECD TG 403 following GLP principles. The animals were exposed to 0 (control – purified air) or 2350 mg/m³ test article in a nose-only exposure system and were examined for clinical symptoms and mortalities during the exposure at 1, 2, and 4 hours, as well as 2 hours after the exposure and daily thereafter for 14 days. Body weights were recorded immediately prior to exposure and on days 7 and 14 of the observation period. Gross pathological examinations were performed on all animals, which were killed after 14 days by ether anaesthesia. Particular attention was given to the respiratory tract.
Upon a 4hour aerosol inhalation exposure and a 14 day post-treatment observation period, no mortalities were elicited by the test substance at a concentration of 2350 ± 100 mg/m3. Due to the properties of the test material, it was not possible to generate higher aerosol concentrations of the test substance. The mass median aerodynamic diameter (MMAD) of the particles was between 1.9 and 2.8 µm, with a geometric standard deviation (GSD) of 2.2 to 2.5. In the vicinity of the animals, 84 to 95 % of the airborne particle mass had a diameter smaller than 7 µm. The animals of both sexes exposed to the test substance experienced the symptoms piloerection, hunched posture and dyspnoea to a similar extent. They recovered within 2 days. From the absence of mortalities it can be assumed that the LC50 to male and female rats is greater than 2350 mg/m3 air.
In conclusion, the acute inhalation LC50 of the test substance in rats was found to be greater than 2350 mg/m3 for both males and females.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.